| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 85.261 | 99.385 | 126.414 | 191.302 | 167.981 | 134.647 | 207.281 | 269.758 | 321.851 | 281.066 |
| Total Income - EUR | 85.982 | 99.694 | 126.501 | 192.110 | 194.475 | 145.584 | 208.859 | 310.380 | 368.819 | 291.266 |
| Total Expenses - EUR | 75.628 | 91.256 | 107.880 | 160.546 | 157.855 | 109.144 | 143.959 | 217.993 | 276.299 | 250.441 |
| Gross Profit/Loss - EUR | 10.354 | 8.438 | 18.621 | 31.564 | 36.620 | 36.440 | 64.900 | 92.387 | 92.520 | 40.825 |
| Net Profit/Loss - EUR | 7.751 | 5.890 | 16.258 | 29.644 | 34.678 | 35.087 | 62.816 | 89.291 | 88.836 | 32.087 |
| Employees | 1 | 2 | 3 | 4 | 4 | 4 | 4 | 5 | 6 | 7 |
Check the financial reports for the company - Homeodent Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 72.513 | 61.328 | 61.202 | 89.625 | 64.755 | 31.087 | 41.244 | 75.417 | 34.584 | 170.610 |
| Current Assets | 4.694 | 7.061 | 16.794 | 22.929 | 63.513 | 61.585 | 126.393 | 65.884 | 95.202 | 42.507 |
| Inventories | 293 | 400 | 1.041 | 602 | 458 | 608 | 941 | 5.991 | 983 | 284 |
| Receivables | 3.675 | 6.328 | 8.170 | 814 | 2.128 | 2.723 | 339 | 2.975 | 9.585 | 2.284 |
| Cash | 726 | 333 | 7.583 | 21.513 | 60.927 | 58.253 | 125.112 | 56.918 | 84.635 | 39.940 |
| Shareholders Funds | 45.752 | 44.495 | 53.433 | 74.223 | 99.302 | 85.761 | 146.675 | 89.340 | 111.259 | 139.106 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 32.322 | 24.095 | 27.276 | 39.485 | 29.415 | 7.245 | 22.483 | 53.453 | 19.018 | 82.997 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Homeodent Srl